Literature DB >> 30764647

A study investigating the validity of an accelerometer in quantification of step count in adult hospital inpatients recovering from critical illness.

Jayne Lesley Anderson1,2, L Samantha Yoward2, Angela J Green1.   

Abstract

OBJECTIVE: To determine the validity of the ActiGraph GT3X accelerometer in step count quantification when compared to observed step count in hospitalised adults recovering from critical illness.
SETTING: Large National Health Service (NHS) Hospitals Trust.
SUBJECTS: In total, 20 hospital ward-based adults (age: mean 62.3, SD 11.5) who had required greater than 48 hours of mechanical ventilation in the intensive care unit. MAIN MEASURES: Participants walked self-selected distances and speeds as part of a semi-structured movement protocol not exceeding 3 hours. Two ActiGraph GT3X accelerometers were worn, one on the thigh and one on the ankle of the non-dominant leg. Accelerometer-recorded step counts were compared against observed step counts.
RESULTS: In total, 31 separate walking episodes were analysed. A mean (SD) of 45.87 (±19.72) steps was calculated for observed step count (range 15-90). Mean differences (95% limits of agreement) of -0.84 steps (-3.88 to 2.2) for the ankle placement and -17.7 steps (-40.63 to 5.25) for the thigh were calculated. Intraclass correlation coefficients (95% confidence intervals) of 0.99 (0.99 to 1.0) and 0.46 (-0.1 to 0.78) were determined for the ankle and thigh, respectively. Placement sites were well tolerated by 95% of participants.
CONCLUSION: An ankle-mounted ActiGraph GT3X accelerometer demonstrates validity in quantification of step count in hospitalised adults recovering from critical illness. A thigh placement was not considered valid.

Entities:  

Keywords:  Accelerometry; activity; critical illness; step count; validity

Mesh:

Year:  2019        PMID: 30764647     DOI: 10.1177/0269215519829893

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  Walking activity in a large cohort of boys with Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Tanja Taivassalo; Claudia R Senesac; Rebecca J Willcocks; Ann M Harrington; Kirsten Zilke; Hilary Cunkle; Catherine Powers; Erika L Finanger; William D Rooney; Gihan I Tennekoon; Krista Vandenborne
Journal:  Muscle Nerve       Date:  2020-11-27       Impact factor: 3.217

2.  The validity of activity trackers is affected by walking speed: the criterion validity of Garmin Vivosmart® HR and StepWatch 3 for measuring steps at various walking speeds under controlled conditions.

Authors:  Frederik Rose Svarre; Mads Møller Jensen; Josephine Nielsen; Morten Villumsen
Journal:  PeerJ       Date:  2020-07-14       Impact factor: 2.984

Review 3.  Potentials and Challenges of Pervasive Sensing in the Intensive Care Unit.

Authors:  Anis Davoudi; Benjamin Shickel; Patrick James Tighe; Azra Bihorac; Parisa Rashidi
Journal:  Front Digit Health       Date:  2022-05-17

4.  Fine Detection of Human Motion During Activities of Daily Living as a Clinical Indicator for the Detection and Early Treatment of Chronic Diseases: The E-Mob Project.

Authors:  David Thivel; Alice Corteval; Jean-Marie Favreau; Emmanuel Bergeret; Ludovic Samalin; Frédéric Costes; Farouk Toumani; Christian Dualé; Bruno Pereira; Alain Eschalier; Nicole Fearnbach; Martine Duclos; Anne Tournadre
Journal:  J Med Internet Res       Date:  2022-01-14       Impact factor: 5.428

Review 5.  Criterion validity of ActiGraph monitoring devices for step counting and distance measurement in adults and older adults: a systematic review.

Authors:  Armelle-Myriane Ngueleu; Corentin Barthod; Krista Lynn Best; François Routhier; Martin Otis; Charles Sèbiyo Batcho
Journal:  J Neuroeng Rehabil       Date:  2022-10-17       Impact factor: 5.208

6.  Quantifying Step Count and Oxygen Consumption with Portable Technology during the 2-Min Walk Test in People with Lower Limb Amputation.

Authors:  John D Smith; Gary Guerra
Journal:  Sensors (Basel)       Date:  2021-03-16       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.